About this trial
Addressing cognitive deficits in alcohol use disorder (AUD) supports recovery. Impaired metacognitive functioning in AUD causes compromised recognition of the interoceptive state leading to the maintenance of alcohol abuse despite negative consequences. By promoting greater self-awareness and self-regulation, neurofeedback training is of high relevance in metacognition remediation to support abstinence.
The main objective of the present study is to validate neurofeedback as a complementary clinical tool to overcome metacognitive deficits that represent a significant factor in the maintenance of harmful consumption behavior and relapse phenomena in AUD.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged between 18 and 65 years old undergoing a 3- to 4-week detoxification treatment program at the Alcohol Unit of CHU Brugmann hospital (Brussels, BELGIUM), who have been diagnosed with severe AUD (alcohol use disorder) according to the DSM-V-TR.
Disqualifiers
history of neurological disorders
other serious medical conditions
neuroleptic treatment are excluded.
Trial design
Parallel
Treatments tested in this trial
Neurofeedback active
DeviceNeurofeedback uses real-time displays of brain activity to teach self regulation of brain function. People can learn to control their own brain activity through operant conditioning, where they receive feedback on their brainwaves and learn to modify them to achieve a desired state. Active neurofeedback group aims at enhancing the sensorimotor rhythm (12-15 Hz).
Neurofeedback placebo
DeviceNeurofeedback uses real-time displays of brain activity to teach self regulation of brain function. People can learn to control their own brain activity through operant conditioning, where they receive feedback on their brainwaves and learn to modify them to achieve a desired state. Placebo feedback group (PFT) : patients enhance random frequency bands
Treatment groups
Trial outcomes
Primary outcomes
Event related potential
Error related negativity (ERN) measurement
Event related potential
Error related negativity (ERN) measurement
Metacognition questionnaire-30 (MCQ-30)
Metacognitive assessment by means of a questionnaire. Scores from 6 to 24, with higher scores meaning worse outcomes.
Metacognition questionnaire-30 (MCQ-30)
Metacognitive assessment by means of a questionnaire. Scores from 6 to 24, with higher scores meaning worse outcomes.
Secondary outcomes
Commission error rate
Behavior assessment
Commission error rate
Behavior assessment
Reaction times
Behavior assessment
Abstinence
Number of days of abstinence
Sponsors and contacts
Click on the lead sponsor to view all of their trials.